Accurate treatment of obesity and type 2 diabetes by weight loss and metabolic surgery

country:China
industry field:Biological medicine
release unit:河北医科大学第二医院
demand unit:The Second Hospital of Hebei Medical University
cooperation mode:unlimited
2023-06-06 18:16:28 11
Project description
The influencing factors of the effect of weight loss metabolic surgery on obesity with type 2 diabetes. 2. 2. How to reduce postoperative complications of weight loss metabolic surgery. 3. Standardized follow-up process for patients undergoing weight loss and metabolic surgery. 4. Why should young surgeons start learning metabolic surgery for weight loss. 5. The reference significance of foreign databases of patients undergoing weight loss and metabolic surgery for us. Objective 1. To further achieve the precise treatment of obesity and type 2 diabetes by weight loss metabolic surgery. 2. Promote the development of weight loss and metabolic surgery in our province. Type 2 diabetes and other metabolic disorders syndrome, mostly (80%) caused by obesity, have become a serious threat to the health of our people's major chronic diseases. The incidence rate of diabetes and obesity in China is 11.6% and 11.3% respectively. The traditional metabolic disorder syndrome such as type 2 diabetes, mostly (80%) caused by obesity, has become a serious threat to our national health of major chronic diseases. The incidence rate of diabetes and obesity in China is 11.6% and 11.3% respectively. Traditional treatments, including diet, exercise, medication, education, and monitoring, no longer meet clinical needs. The International diabetes Federation (IDF) takes metabolic surgery (sleeve gastrectomy and gastric bypass surgery) as an effective measure to treat obese patients with type 2 diabetes. Our hospital is one of the largest comprehensive tertiary A hospitals in Hebei Province. Surgery is a provincial-level key discipline, and its eight departments of general surgery are the earliest and most numerous units in Hebei Province to carry out weight loss and metabolic surgery. The department has medical equipment related to metabolic surgery, such as laparoscopy, electronic gastroscopy, electronic duodenoscopy, cholangioscopy, bedside ultrasound, body fat analyzer, respiratory sleep detection system, non-invasive ventilator, etc. At present, clinical research and basic research on laparoscopic metabolic surgery for obesity and type 2 diabetes have been carried out, and satisfactory results have been achieved. Although metabolic surgery has proven to be effective in reducing weight and blood sugar in large hospitals and medical centers abroad, it is still in its infancy in our province and even in China. Therefore, it is planned to introduce foreign high-level medical talents in the field of weight-loss metabolic surgery, promote the development of weight-loss metabolic surgery in our province, and better benefit the majority of obese and type 2 diabetes patients.

contact:

contact information:

company address:河北省石家庄市和平西路215号

Company profile:河北医科大学第二医院前身为1918年1月成立的直隶公立医学专门学校附设诊所,1920年扩建为医院,1958年迁至石家庄市,2013年设立东院区,北院区、西山医养一体化医院、正定新区医院正在建设中。目前,医院已成为河北省最大的一所集医疗、教学、科研、保健、康复、急救为一体的综合性三级甲等医院。为亚洲国际救援会员单位、国家级爱婴医院、首批全国百姓放心示范医院;国家药物临床试验机构,卫生部腔镜培训基地,卫生部冠心病介入治疗培训基地,中华医学会腹腔镜内镜学培训基地,河北省神经内科、麻醉、急诊、影像、核医学、检验、护理、病历等多个省级质量控制中心所在单位。医院编制床位2816张,2015年门急诊总量217万人次,出院病人13万人次,手术26661例。医院人才济济,技术力量雄厚。拥有中国工程院院士1人、河北省高端人才1人,博士生导师25人,享受国务院特殊津贴专家、省管专家、省有突出贡献中青年专家59人。医院科室专业齐全,综合实力居全省首位,其中心血管内科、心脏大血管外科、神经内科、眼科、呼吸内科、急诊科、麻醉科和临床护理专业为国家重点临床专科;内科学为河北省强势特色学科(群);内科学、外科学、神经内科学为省级重点学科;神经内科、心血管内科、消化内科、血液内科、呼吸内科、泌尿外科、眼科、妇产科、神经外科、心血管外科、小儿外科、耳鼻喉科、普外科、病理科、医学影像科为省级医学重点学科;急诊科为省级医学重点发展学科。医院多数临床科室为省内学术牵头单位,每年主办、承办国际、国内、省内等大型高层次学术会议交流40余次。医院每年开展多项国内外领先技术疗法。其中经前臂动脉微创化冠脉介入治疗技术,心脏冠脉搭桥技术,器官移植技术,造血干细胞移植技术,“体外受精、胚胎移植”技术,肿瘤生物治疗技术等达到国内先进水平。医院高度重视医学科技研究。拥有河北省心脑血管病研究所、呼吸病研究所、消化病研究所、血液病研究所等21个医学研究所、中心、室。临床神经病学实验室为省部共建重点实验室,神经病学、消化病学、血液病学、血管稳态实验室为省级重点实验室。河北省心脑血管病协同防治中心是省内医疗系统唯一建设于医院的中心。近年来,医院承担国家自然基金项目36项,国家863子课题3项, “十二五” 国家科技支撑计划子课题8项;荣获国家科技进步二等奖1项、河北省科技进步一等奖5项、二等奖9项、三等奖57项。医院为河北医科大学第二临床医学院, 16个专业为博士学位培养点,33个专业为硕士学位培养点;拥有6项省级精品课程;每年在院学生近2000名,其中博士、硕士研究生近1000名。医院以严控基础质量为立院之本,实现了全程、全员医疗质量控制管理。积极创新医疗服务模式,在省内率先开通一站式预约诊疗中心、肿瘤诊疗会诊中心、院内会诊系统等,全年365天开诊、急诊24小时接待患者,良好的行业作风、优秀的人才队伍、精湛的医疗技术、现代化的医疗设备及人性化服务得到了社会各界的广泛赞誉

  • 2022-11-02 18:02 *** 电话联系了该立项企业
  • 2022-11-02 18:02 *** 电话联系了该立项企业
  • 2022-11-02 18:02 *** 电话联系了该立项企业
  • 2022-11-02 18:02 *** 电话联系了该立项企业
  • 2022-11-02 18:02 *** 电话联系了该立项企业
related item
Intelligent Supply Chain Planning and Advanced Manufacturing Equipment Technology for Modern Traditional Chinese Medicine Manufacturing

country:China

release time:2023-07-12

release unit:神威药业集团有限公司

core technology:Intelligent manufacturing of traditional Chinese medicine

demand unit:Shenwei Pharmaceutical Group Co., Ltd

cooperation mode:Project cooperation

participate in the project
Development of sustained-release microspheres for injection

country:China

release time:2023-07-12

release unit:石家庄四药有限公司

core technology:Development of sustained-release microspheres for injection

demand unit:Shijiazhuang Siyao Co., Ltd

cooperation mode:Project cooperation

participate in the project
Cooperative education projects

country:Japan

release time:2023-06-06

release unit:河北寰球才智网

core technology:Cooperative education projects

demand unit:Hebei Media College

cooperation mode:unlimited

participate in the project
Technical Requirements for Drilling Hard and Brittle Materials

country:China

release time:2023-06-06

release unit:河北挚诚莱皓科技服务有限公司

demand unit:Hebei Zhicheng Laihao Technology Service Co., Ltd

cooperation mode:unlimited

participate in the project
Hebei Global Intelligence Information
X
Hello! Hebei Huanqiu Intelligence Network Customer Service Xiaohui will serve you wholeheartedly~
You can leave questions and contact information, and special personnel will contact you~
name *
telephone *
problem *
Thank you for your message~ Close the window